Claritev Corp(CTEV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -17.01 | Insider Own | 48.73% | Shs Outstand | 16.9M | Perf Week | 2.13% |
| Market Cap | 0.41B | Forward P/E | - | EPS next Y | 10.51% | Insider Trans | 1.86% | Shs Float | 8.7M | Perf Month | 13.37% |
| Enterprise Value | 5.08B | PEG | - | EPS next Q | -3.63 | Inst Own | 48.95% | Short Float | 10.56% | Perf Quarter | 5.68% |
| Income | -0.28B | P/S | 0.41 | EPS this Y | 12.62% | Inst Trans | -9.93% | Short Ratio | 5.62 | Perf Half Y | -1.36% |
| Sales | 0.99B | P/B | - | EPS next 5Y | 11.9% | ROA | -5.76% | Short Interest | 0.92M | Perf YTD | -43.86% |
| Book/sh | -17.39 | P/C | 14.69 | EPS past 3/5Y | 21.58% 17.12% | ROE | -646.34% | 52W High | -67.43% ($73.68) | Perf Year | -65.01% |
| Cash/sh | 1.63 | P/FCF | - | Sales past 3/5Y | -3.66% 0.58% | ROIC | -6.47% | 52W Low | 108.7% ($11.50) | Perf 3Y | -63.64% |
| Dividend Est. | - | EV/EBITDA | 10.37 | EPS Y/Y TTM | 58.48% | Gross Margin | 28.18% | Volatility(W/M) | 8.03% 6.72% | Perf 5Y | -86.08% |
| Dividend TTM | - | EV/Sales | 5.1 | Sales Y/Y TTM | 6.32% | Oper. Margin | 4.21% | ATR (14) | 1.72 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1 | EPS Q/Q | 8.3% | Profit Margin | -28.46% | RSI (14) | 46.72 | Recom | 1.6 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1 | Sales Q/Q | 6.59% | SMA20 | 2.12% ($23.5) | Beta | 1.09 | Target Price | $46 |
| Payout | - | Debt/Eq | - | Earnings | 2026/11/9 | SMA50 | -17.94% ($29.25) | Rel Volume | 1.75 | Prev Close | $23 |
| Employees | 3000 | LT Debt/Eq | - | EPS/Sales Surpr. | 15.32% 5.17% | SMA200 | -6.62% ($25.7) | Avg Volume(3M) | 0.16M | Price | $24 |
| IPO | 2020/4/3 | Option/Short | Yes/Yes | Trades | 3199 | Volume | 284,927 | Change | 4.35% |
Claritev is a U.S. healthcare technology company specializing in medical cost management, payment integrity, and data analytics. It provides claim cost reduction, network analysis, and data-driven insight solutions to insurance companies and payers, with a business model that leverages an extensive repository of claims data to support transparency and efficiency in healthcare costs.
Over the past 1 year, on the lower side
67% below its 1-year high.
Traded more than usual. That is 175% of its average volume.
Next earnings report: November 9
10 days to go.
CTEV keeps an operating profit but posts a net loss
Of every $100 in sales, $4.21 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.6% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $41. Peers typically go for $181. Compared with its own 1-year average, it is 68% cheaper now.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -86.1%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 49.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #23 of 41 in the industry
Based on market cap of $407M.
WEAV#19 Weave Communications Inc $595M PER - 
NRC#20 NRC Health $520M PER 84.5 
EVH#21 Evolent Health Inc $481M PER - 
CARL#22 Carlsmed Inc $431M PER - CTEV#23 Claritev Corp $407M PER - 
FAQ
What kind of company is CTEV?
CTEV belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of CTEV?
The market cap of CTEV is approximately $407M, ranking 3,327 within its sector.
What is the 52-week high and low for CTEV?
CTEV has recorded a 52-week high of $73.68 and a low of $11.50.
